Canada markets close in 5 hours 43 minutes

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
77.45-2.90 (-3.61%)
As of 11:59AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
49,584,000
48,677,000
53,166,000
50,135,000
49,436,000
Cost of Revenue
14,896,000
14,425,000
18,407,000
17,175,000
17,520,000
Gross Profit
34,688,000
34,252,000
34,759,000
32,960,000
31,916,000
Operating Expenses
Research Development
9,500,000
9,402,000
9,074,000
8,972,000
9,039,000
Selling General and Administrative
14,178,000
14,369,000
16,471,000
14,997,000
14,192,000
Total Operating Expenses
25,357,000
25,166,000
26,590,000
24,331,000
23,648,000
Operating Income or Loss
9,331,000
9,086,000
8,169,000
8,629,000
8,268,000
Interest Expense
923,000
902,000
957,000
777,000
707,000
Total Other Income/Expenses Net
522,000
499,000
6,372,000
1,062,000
233,000
Income Before Tax
9,078,000
8,940,000
13,835,000
8,999,000
7,817,000
Income Tax Expense
1,977,000
1,793,000
1,221,000
1,296,000
1,119,000
Income from Continuing Operations
7,101,000
7,147,000
12,614,000
7,703,000
6,698,000
Net Income
7,103,000
11,732,000
12,611,000
7,703,000
6,712,000
Net Income available to common shareholders
7,103,000
11,732,000
12,611,000
7,703,000
6,712,000
Basic EPS
-
5.12
5.44
3.28
2.82
Diluted EPS
-
5.06
5.38
3.25
2.80
Basic Average Shares
-
2,291,000
2,319,000
2,346,000
2,378,000
Diluted Average Shares
-
2,319,000
2,344,000
2,371,000
2,400,000
EBITDA
-
15,668,000
21,684,000
15,852,000
14,567,000